Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Clinical features and prognosis of nasal type NK/T cell lymphoma]

[Clinical features and prognosis of nasal type NK/T cell lymphoma] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Clinical features and prognosis of nasal type NK/T cell lymphoma] Abstract Text:

    yu-jing zhangYu-jing Zhang,wei-han huWei-han Hu,hui liuHui Liu,er-cheng chengEr-cheng Cheng,zhong-min renZhong-min Ren,yun-fei xiaYun-fei Xia,nian-ji cuiNian-ji Cui,yu-jing zhangYu-jing Zhang,wei-han huWei-han Hu,hui liuHui Liu,er-cheng chengEr-cheng Cheng,zhong-min renZhong-min Ren,yun-fei xiaYun-fei Xia,nian-ji cuiNian-ji Cui,

    OBJECTIVE: To investigate the clinical features, treatment modalities and the prognosis of nasal type NK/T cell lymphoma. METHODS: The data of 39 such patients treated from June 2000 to December 2003 were retrospectively reviewed. Twenty three patients were treated by combined chemoradiotherapy, basing on anthracycline-containing CHOP or similar regimens (median 5 cycles). Eleven patients by chemotherapy alone, 2 by radiotherapy alone and 2 aged patients by palliative chemotherapy or radiotherapy. Radiotherapy was given by high energy photon ray combined with electron beam with a median curative dose of 56 Gy in conventional fractionation. Bivariate correlations and univariate prognostic factors were analyzed. RESULTS: Median follow-up time for the 21 patients who were still alive was 22.5 months. The overall remission rate (RR) after initial treatment was 66.7% (21 CR, 3 PR). Chemotherapy alone got a CR rate of only 37.5%. The overall local control rate was 59.4%. Local relapse rate after curative radiotherapy was 25.0%. Radiotherapy was positively correlated with local control (P = 0.000) and time to disease progression (TTP, P = 0.002). Skin and intestine were among the extranodal relapse sites. Fifteen patients had highly aggressive tumors with a median survival time of only 5 months. Univariate analysis showed that significant favorable survival prognostic factors were: radiotherapy (P = 0.001); lower risk International Prognostic Index (IPI, P = 0.001); complete remission after primary treatment (P = 0.000); pre-diagnostic history > 2 months (P = 0.024); and free of skin involvement (P = 0.034). CONCLUSION: Most of nasal type NK/T cell lymphoma are in early stage when diagnosed. Radiotherapy remains to be the mainstay of treatment. Combined chemoradiotherapy needs further improvement for the progressive disease type. Some patients may have highly aggressive tumors with poor prognosis. Optimal prognostic factors and individualized treatment regimens need to be investigated.

    [Clinical features and prognosis of nasal type NK/T cell lymphoma] Publishing Authors By Initials

    yj zhangYJ Zhang,wh huWH Hu,h liuH Liu,ec chengEC Cheng,zm renZM Ren,yf xiaYF Xia,nj cuiNJ Cui,yj zhangYJ Zhang,wh huWH Hu,h liuH Liu,ec chengEC Cheng,zm renZM Ren,yf xiaYF Xia,nj cuiNJ Cui,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Clinical features and prognosis of nasal type NK/T cell lymphoma] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Zhonghua zhong liu za zhi [Chinese journal of onco

    VOLUME: 28

    Page Numbers: 50-3

    Journal Abbreviation: Zhonghua Zhong Liu Za Zhi

    ISSN: 0253-3766

    DAY: 1

    MONTH: Jan

    YEAR: 2006

    [Clinical features and prognosis of nasal type NK/T cell lymphoma] Information

    Number of References:

    LANGUAGE: chi

    NlmUniqueID: 7910681

    [Clinical features and prognosis of nasal type NK/T cell lymphoma] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Clinical features and prognosis of nasal type NK/T cell lymphoma] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Clinical features and prognosis of nasal type NK/T cell lymphoma]

    AFFILIATION: Department of Radiation Oncology, Cancer Center, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University, Guangzhou 510060, China. zyjdr@sohu.com

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Zhonghua Zhong Liu Za Zhi

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Clinical features and prognosis of nasal type NK/T cell lymphoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News